Latest California Healthline Stories
An amino acid infusion called NAD is not approved by the FDA to treat addiction. Yet patients with addiction can be desperate enough to try it, at prices as high as $15,000.
MDMA, the psychoactive ingredient in the club drug known as molly or ecstasy, is being tested in combination with therapy as a treatment for severe trauma.
It can be difficult to get a prescription for buprenorphine, one of the gold standards for treating opioid use disorder. And not all pharmacies stock the drug.
Tennessee’s innovative Medicaid program is offering bonuses to mental health providers who help make sure their Medicaid patients get preventive help and treatment for physical ailments, too.
The recent tragic mass shootings have refocused efforts to treat gun violence as a public health issue rather than strictly a law enforcement problem. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this, plus the health implications of the budget deal passed by Congress and signed by President Donald Trump, as well as reaction from Canada to a proposal to allow broader imports of its prescription drugs. Plus, for “extra credit,” the panelists recommend their favorite health stories of the week.
Veronica Kelley, head of San Bernardino County’s Department of Behavioral Health, knows firsthand that the mental health effects from mass shootings linger. Nearly four years after her community was devastated by a massacre of 14 people, Kelley has advice for Gilroy, El Paso, Dayton and other communities reeling from recent carnage.
So-called red flag laws that let police take guns away from people with mental illness have support from both advocates and opponents of gun control. But it won’t alleviate gun violence.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHN’s Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.
A KHN review of dozens of inspection reports filed over the past year by the Nakamoto Group reveals disturbing patterns about the company’s audits, including a general willingness to accept accounts of the facilities that the company is paid to scrutinize, and to discount detainees’ complaints.